Published on
For a patient with a measles infection, the health effects can last well beyond the acute illness. The measles virus destroys memory B and T cells that help the immune system recognize previously encountered pathogens, producing “immune amnesia,” according to an analysis in CIDRAP. As a result, patients can lose protection acquired through prior infections or vaccination and become susceptible again to bacterial and viral illnesses. Studies suggest measles survivors may lose 11%–73% of their preexisting antibodies, with recovery taking 2–3 years. Increased infection risk can continue for up to 5 years, according to the analysis. As of October 2, 2026, there were 3,887 confirmed measles cases reported in the United States for the year so far.
Bounce backs: Urgent care clinicians may encounter recurrent infections—including respiratory infections, ear infections, and pneumonia—that represent lingering immune effects after measles infection. Asking questions at the bedside and reviewing any documented patient history for measles can be helpful. Although the immune system gradually rebuilds its defenses, it’s impossible to predict which type of immunity an individual patient has lost. There is also no universal recommendation to revaccinate patients after measles, although booster shots may be considered individually for patients based on clinical need.